Palliative und supportive Therapie des Ösophaguskarzinoms

作者: S. Lorenzen , J.T. Siveke , B. van Oorschot

DOI: 10.1007/S00761-014-2761-8

关键词:

摘要: Hintergrund Die Prognose des Osophaguskarzinoms im fortgeschrittenen Stadium ist ungunstig, und die Palliativtherapie dieser Patienten erfordert ein breites Spektrum unterschiedlicher Masnahmen zur Linderung der Beschwerden. Dennoch eroffnet das zunehmende Verstandnis Tumorbiologie Plattenepithel- Adenokarzinoms Speiserohre Chance auf verbesserte Therapiemoglichkeiten.

参考文章(31)
P C Enzinger, D H Ilson, D P Kelsen, Chemotherapy in esophageal cancer Seminars in Oncology. ,vol. 26, pp. 12- 20 ,(1999)
Aravamuthan Sreedharan, Keith Harris, Adrian Crellin, David Forman, Simon M Everett, Interventions for dysphagia in oesophageal cancer Cochrane Database of Systematic Reviews. ,(2009) , 10.1002/14651858.CD005048.PUB2
J. Ruediger Siewert, Hubert J. Stein, Marcus Feith, Björn L.D.M. Bruecher, Holger Bartels, Ulrich Fink, Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World Annals of Surgery. ,vol. 234, pp. 360- 369 ,(2001) , 10.1097/00000658-200109000-00010
Tak Yun, Ji-Youn Han, Jin Soo Lee, Hyun Lee Choi, Hyae Young Kim, Byung-Ho Nam, Heung Tae Kim, Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma BMC Cancer. ,vol. 11, pp. 385- 385 ,(2011) , 10.1186/1471-2407-11-385
Marjolein YV Homs, Marie-Louise Essink-Bot, Gerard JJM Borsboom, Ewout W Steyerberg, Peter D Siersema, Dutch SIREC Study Group, Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy. European Journal of Cancer. ,vol. 40, pp. 1862- 1871 ,(2004) , 10.1016/J.EJCA.2004.04.021
Bryan H. Burmeister, Euan T. Walpole, Elizabeth A. Burmeister, Janine Thomas, Damien B. Thomson, Jennifer A. Harvey, B. Mark Smithers, David C. Gotley, Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. International Journal of Clinical Oncology. ,vol. 10, pp. 256- 261 ,(2005) , 10.1007/S10147-005-0506-9
H. Bergquist, U. Wenger, E. Johnsson, J. Nyman, H. Ejnell, E. Hammerlid, L. Lundell, M. Ruth, Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Diseases of The Esophagus. ,vol. 18, pp. 131- 139 ,(2005) , 10.1111/J.1442-2050.2005.00467.X
F Gay, L Collette, T Sahmoud, H Bleiberg, T Conroy, B Paillot, A.J Lacave, G Blijham, J.H Jacob, L Bedenne, M Namer, P De Besi, Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer European Journal of Cancer. ,vol. 33, pp. 1216- 1220 ,(1997) , 10.1016/S0959-8049(97)00088-9
C. Kuhn, F. Kullmann, H. Lang, H. Link, F. Lordick, K. Ludwig, M. Lutz, R. Mahlberg, P. Malfertheiner, S. Merkel, H. Messmann, H.-J. Meyer, S. Mönig, P. Piso, S. Pistorius, R. Porschen, T. Rabenstein, P. Reichardt, K. Ridwelski, C. Röcken, I. Roetzer, P. Rohr, W. Schepp, P. Schlag, R. Schmid, H. Schmidberger, W.-H. Schmiegel, H.-J. Schmoll, G. Schuch, C. Schuhmacher, K. Schütte, W. Schwenk, M. Selgrad, A. Sendler, J. Seraphin, T. Seufferlein, M. Stahl, H. Stein, C. Stoll, M. Stuschke, A. Tannapfel, R. Tholen, P. Thuss-Patience, K. Treml, U. Vanhoefer, M. Vieth, H. Vogelsang, D. Wagner, U. Wedding, A. Weimann, H. Wilke, C. Wittekind, M. Moehler, S.-E. Al-Batran, T. Andus, M. Anthuber, J. Arends, D. Arnold, D. Aust, P. Baier, G. Baretton, J. Bernhardt, H. Boeing, E. Böhle, C. Bokemeyer, J. Bornschein, W. Budach, E. Burmester, K. Caca, W. Diemer, C. Dietrich, M. Ebert, A. Eickhoff, C. Ell, J. Fahlke, H. Feußner, R. Fietkau, W. Fischbach, W. Fleig, M. Flentje, H. Gabbert, P. Galle, M. Geissler, I. Gockel, U. Graeven, L. Grenacher, S. Groß, J. Hartmann, M. Heike, V. Heinemann, B. Herbst, T. Herrmann, S. Höcht, R. Hofheinz, H. Höfler, T. Höhler, A. Hölscher, M. Horneber, J. Hübner, J. Izbicki, R. Jakobs, C. Jenssen, S. Kanzler, M. Keller, R. Kiesslich, G. Klautke, J. Körber, B. Krause, [German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"] Zeitschrift Fur Gastroenterologie. ,vol. 49, pp. 461- 531 ,(2011) , 10.1055/S-0031-1273201